TTrialPathMatch Me to Trials
← Back to trials
RecruitingSarcomaGiant Cell Tumor of Bone

PROMIS and Mobility Evaluation in Sarcoma Patients

Eligible age

18+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this is to validate the Patient-Reported Outcomes Measurement Information System (PROMIS) in sarcoma patients undergoing surgery, and to evaluate a novel smartphone app for collecting mobility data. The goals of the study include to: 1. Validate PROMIS as a patient outcome measure in sarcoma 2. Assess the effectiveness of a novel app for administering questionnaires and collecting mobility metrics 3. Compare PROMIS scores and mobility metrics to better evaluate recovery trajectories after surgery Participants will complete PROMIS questionnaires at regularly scheduled intervals using the smartphone app. Questionnaires will be completed pre-operatively and at 6 weeks, 12 weeks, 6 months, and 12 months post-operatively. Additionally, the app will passively track mobility metrics such as daily step count, stairs climbed, and gait parameters to compare with PROMIS scores.

Sponsor: University of Calgary

You may qualify if…

  • Age ≥ 18 years
  • Diagnosis of bone sarcoma, soft tissue sarcoma, or giant cell tumor of bone
  • Tumors located in the pelvis, lower extremities, or upper extremities
  • Primary or recurrent disease
  • Undergoing operative tumor resection, including limb salvage surgery and amputation
  • Has an iPhone or Android phone
  • Speaks English

You may not qualify if…

  • Metastatic bone tumor
  • Diagnosis of atypical lipomatous tumor or dermatofibrosarcoma protuberans
  • Currently pregnant or planning pregnancy within 6 months
  • Unwilling or unable to attend follow-up evaluations
  • Cognitive or communication barriers that impede completion of questionnaires

Where it's recruiting

Arizona

Phoenix

Minnesota

Rochester

Source: ClinicalTrials.gov · NCT07227961 · last updated 2025-11-13

PROMIS and Mobility Evaluation in Sarcoma Patients · TrialPath